Elrifi Ivor reported option exercise involving 1,050,000 derivative units of Tiziana Life Sciences Ltd on Aug 15, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Executive Officer
Chief Executive Officer
Filed Sep 29, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
1,050,000Restricted Stock Unit
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
2,100,000Direct
Trade date
Aug 15, 2026Option exercise
Filed
Sep 29, 2026, 5:13 PM ET45-day reporting delay
Accession
0001213900-26-104755Code M · Transaction 231155
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 15, 2026Option exercise1,050,000——Trade 231154
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
2 warnings
delayed filingThe filing was reported 45 calendar days after the transaction date.
missing priceThe filing did not provide a usable price per share.

TLSA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
TLSA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 6, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of Issuer's common stock. F2: The RSUs were granted on August 15, 2024 vesting in four installments on August 15, 2025, August 15, 2026, August 15, 2027 and August 15, 2028.